Toku Eyes artificial intelligence (AI) engine THEIA has grown since inception in 2018 & seeks to address cardiovascular & ocular disease manifest in the fundus. THEIA's capabilities range from screening, diagnosing & prognosing these various diseases.Our mission is to eliminate preventable health & vision deterioration, & have no relevant disease missed during consultation. Early, accessable & affordable screening, diagnosis & prognosis of disease are our goals. Every consultation could become a Specialist consultation, regardless of where & with whom the patient consults.THEIA is a unique set of AI engines, each specialised in using different imaging modalities for diagnostic, prognostic or health assessment purposes. Image enhancement & other quality parameters are designed into THEIA. It would be a valuable tool for every Eye Healthcare Clinician to help them rapidly identify & action high priority diseases.Millions of parameters are reviewed by THEIA in every image, delivering high sensitivity, specificity & negative predictive values. The diagnostic report is provided in 10 seconds. THEIA's broader attributes can be seen in its ability to determine HbA1c levels & cardiovascular risk factors via the eye, with associated prognostic capability. THEIA in use replicates the way medical Specialists step through a diagnosis. It has been tested on more than 66,000 patients. Implementation of THEIA is intended to augment Clinicians' capabilities, automating mundane tasks performed during a routine eye & health check. THEIA is future-proofed for various imaging modalities & is automated end-to-end from captured image quality check to the final patient-referral letter & report generation. It is device/software platform/ clinician –agnostic & utilises secure & scalable, encrypted Cloud hosting. Regulatory approval submissions are in preparation for the major agencies.Toku Eyes welcomes enquiries from potential clinical, commercial & research partners.

Website: tokueyes.com

Employees: 5 - 9

HQ: N/A

Location: N/A, N/A, NZ

Revenue: Not Available

Toku Eyes is a cutting-edge technology company that provides innovative solutions for businesses. If you're looking for contact information for Toku Eyes, you've come to the right place. At ConnectPlex.ai, we provide accurate and up-to-date contact information for key decision-makers and professionals in the company. Our AI-powered algorithms ensure that our data is always current and reliable, so you can trust that you're getting the right information. Whether you're looking to collaborate, partner, or get in touch with Toku Eyes, ConnectPlex is the perfect platform to help you connect with the right people. With ConnectPlex, you can easily search for contact information for Toku Eyes and get access to a comprehensive database of professionals and decision-makers. Our user-friendly interface and powerful search filters make it easy to find the right contact information quickly and efficiently. Plus, our AI-powered algorithms ensure that our data is always up-to-date, so you can be sure that you're getting the most current information available. Try ConnectPlex today and discover how easy it is to connect with the people that matter most to your business.

Toku Eyes is a medical technology company that has developed an artificial intelligence (AI) engine called THEIA, which is designed to address cardiovascular and ocular diseases through the analysis of medical images. THEIA is capable of screening, diagnosing, and prognosing various diseases, with a focus on early detection and prevention of preventable health and vision deterioration. The AI engine has been tested on over 66,000 patients and has demonstrated high sensitivity, specificity, and negative predictive values. Toku Eyes aims to revolutionize the way eye healthcare clinicians work by providing them with a valuable tool that can rapidly identify and action high-priority diseases. THEIA is designed to replicate the way medical specialists step through a diagnosis, and it is future-proofed for various imaging modalities. The company welcomes enquiries from potential clinical, commercial, and research partners. Ehsan Vaghefi, Co-Founder of Toku Eyes, is leading the company's efforts to eliminate preventable health and vision deterioration through the use of AI technology.

Toku Eyes has developed an artificial intelligence (AI) system called THEIA to help doctors diagnose and treat eye and heart diseases. THEIA can examine images of the eye to identify different diseases, such as diabetes and heart disease, and provide a diagnosis in 10 seconds. It can also determine the risk of heart disease by looking at the eye. THEIA is designed to work like a specialist doctor, and it can do many tasks that a doctor would do during a routine check-up. It can also automatically generate a report and referral letter. THEIA is compatible with different types of imaging technology and is securely hosted on the cloud. Toku Eyes is planning to submit THEIA for approval to major regulatory agencies and is looking for partners to work with.